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EFFECT OF RPON, RPOS AND LUXS PATHWAYS ON THE BIOFILM
FORMATION AND ANTIBIOTIC SENSITIVITY OF BORRELIA
BURGDORFERI
Eva Sapi*, Priyanka A. S. Theophilus, Truc V. Pham, Divya Burugu, David F. Luecke
Department of Biology and Environmental Science, University of New Haven, West Haven, CT 06516, USA
Received: July 20, 2016; Accepted: August 15, 2016
Borrelia burgdorferi, the causative agent of Lyme disease, is capable of forming biofilm in vivo and in vitro, a structure well known
for its resistance to antimicrobial agents. For the formation of biofilm, signaling processes are required to communicate with the
surrounding environment such as it was shown for the RpoN–RpoS alternative sigma factor and for the LuxS quorum-sensing pathways. Therefore, in this study, the wild-type B. burgdorferi and different mutant strains lacking RpoN, RpoS, and LuxS genes were
studied for their growth characteristic and development of biofilm structures and markers as well as for their antibiotic sensitivity.
Our results showed that all three mutants formed small, loosely formed aggregates, which expressed previously identified Borrelia
biofilm markers such as alginate, extracellular DNA, and calcium. All three mutants had significantly different sensitivity to doxycyline in the early log phase spirochete cultures; however, in the biofilm rich stationary cultures, only LuxS mutant showed increased sensitivity to doxycyline compared to the wild-type strain. Our findings indicate that all three mutants have some effect on
Borrelia biofilm, but the most dramatic effect was found with LuxS mutant, suggesting that the quorum-sensing pathway plays an
important role of Borrelia biofilm formation and antibiotic sensitivity.
Keywords: Lyme disease, biofilm, sigma factor, quorum sensing, mucopolysaccharides, alginate, eDNA
Abbreviations: BSA, bovine serum albumin; BSK-H, Barbour–Stoner–Kelly H; DAPI, 4',6-diamidino-2-phenylindole; DDAO,
7-hydroxy-9H-(1,3-dichloro-9,9 dimethylacridin-2-one; DIC, differential interference contract microscopy; EDTA, ethylenediaminetetraacetic acid; EPS, extracellular polymeric substances; FITC, fluorescein isothiocyanate; PBS, phosphate-buffered saline;
RT, room temperature; TE, Tris–EDTA

Introduction
Lyme disease is the most common tick-borne illness
caused by the species of bacteria belonging to the genus
Borrelia [1]. According the Center of Disease Control
within the United States, there are approximately 300,000
reported new Lyme disease cases every year while there
are 65,000 people per year reported in Europe [2]. Patients
diagnosed with Lyme disease are treated with certain antibiotics; however, recent studies demonstrated those antibiotics insufficient in eliminating certain forms of Borrelia
in vitro [3–6]. Furthermore, several clinical [7–12] and in
vivo studies [13–18] suggested that there are a potential

resistant form which can withhold the antibiotic treatments
and the attack of the immune system.
Numerous studies demonstrated that Borrelia burgdorferi can adopt diverse morphologies such as spirochete,
round bodies (cysts and granules), and cell deficient forms
depending on the condition of the environment they are
exposed to [19–23]. These forms provide protective environment for Borrelia for adverse environmental conditions
such as exposure to antibiotics, starvation, pH changes, or
even high temperature [24–31]. In these defensive forms,
B. burgdorferi becomes dormant and remains in this morphological state until it finds a more favorable condition
when it returns to its spirochete form [27–31].
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Recently, we provided evidences that B. burgdorferi
sensu stricto and sensu lato stains are capable of forming another defensive form called biofilm both in vitro and
in vivo [32, 34]. We also suggested that Borrelia biofilm
formation could result in increased resistance to various
antibiotics [3, 35]. Numerous studies showed that one of
the most effective hiding places for a bacterial species is
biofilm [36, 37]. Bacterial biofilms are organized communities of cells enclosed in a self-produced hydrated polymeric matrix called extracellular polymeric substances
(EPS) which are complex mixtures of polysaccaharides,
lipids proteins, nucleic acids, and other macromolecules
[36–39]. Elimination of pathogenic bacteria in their biofilm form is very challenging because these sessile bacterial cells can endure not just the host immune responses
but they are much less susceptible to antibiotics or any
other industrial biocides than their individual planktonic
counterparts [38, 39]. The biofilm resistance is based upon
multiple mechanisms, such as incomplete penetration of
certain antibiotics deep inside the matrix and/or inactivation of antibiotics by altered microenvironment within the
biofilm and a highly protected resistant bacteria population
called persisters [39].
When we evaluated the possibilities that observed Borrelia aggregates are indeed biofilm structures, its important
biofilm traits like structural rearrangements and changes in
development on different substrate matrices as well as the
different components of the extracellular protective polymeric surface were studied [32, 33]. Our atomic force microscopic results provided evidence that, at various stages
of aggregate development, rearrangements take place at
multiple levels that lead to a continuously complex rearranging structure [32]. When the EPS of the aggregates
was studied for potential exopolysaccharides, both sulfated and non-sulfated/carboxylated substrates were found;
however, the majority was non-sulfated polymucosaccharide alginate. We provided evidence that the Borrelia
EPS matrix also contains calcium and extracellular DNA
[32, 33].
The important molecular pathways of Borrelia biofilm
development are not known; therefore, to better understand the key components, the potential role of the several
important signaling pathways was studied using wild-type
and mutant B. burgdorferi sensu stricto strain 297.
The first pathway targeted was the RpoN–RpoS alternative sigma factor pathways, which can be found in
many bacterial species, and they are involved in various
cellular functions in response to different environmental
stresses such as adverse temperature, high/low pH, high
osmolarity, oxidative stress, high cell density, and carbon
starvation [40]. They also control important virulence
factors, and they are required for successful infection by
many pathogenic bacteria [40]. The RpoN–RpoS pathway
in B. burgdorferi has similar functions and responsible
for sensing the environmental cues and activating RpoN
encoded for σN which then regulates another alternative
sigma factor, σS [41–45]. It was shown that this two-component RpoN–RpoS signal-transduction pathway controls
European Journal of Microbiology and Immunology

the successful transmission of B. burgdorferi from the arthropod vector to the vertebrae host by regulating the expression of several known virulence factors such as outer
surface proteins (OspA, OspB, OspC), decorin and fibronectin binding proteins as well as other proteins [44–46].
RpoS-mediated adaptive response is directly regulated by
RpoN in B. burgdorferi, and together, they regulate over
100 different genes important in survival and stress responses as well as genes involved in the infectious cycles
of B. burgdorferi [44–46].
Another important global regulatory pathway in bacteria is the quorum sensing bacterial intercommunication
system that controls the expression of multiple genes in
response to population density [47–50]. The system utilizing small signal molecules is called autoinducers. As
the cell population density increases, autoinducers accumulate and cause a population-wide change in the expression of different genes involved in biofilm formation
[49, 50]. It was previously demonstrated that B. burgdorferi utilizes the autoinducer-2 as one of its many
ways of communication [51, 52]; however, one study
challenged this observation [53]. The importance of this
quorum-sensing pathway in biofilm development was
shown for several pathogenic bacteria [54, 55]. For example, a luxS mutant of Streptococcus gordonii, a major
component of dental plaque biofilm, was unable to form
a mixed-species biofilm with another pathogen Porphyromonas gingivalis [54]. Furthermore, the luxS mutant of
Streptococcus spp. shows altered biofilm structure [55].
All these data suggest that LuxS quorum sensing system
might play an important role in B. burgdorferi biofilm
formation.
In this study, different B. burgdorferi strains including the wild-type 297 and several mutant strains such as
RpoN, RpoS, and LuxS mutants were studied to evaluate
the effect of the deletion of these genes on biofilm formations and biofilm specific markers as well as antibiotic
sensitivity of B. burgdorferi in order to better understand
the molecular pathways involved in biofilm formation and
its antibiotic resistance. Several previously described Borrelia biofilm markers such as sulfated/non-sulfated polysaccharides, alginate, extracellular DNA, and calcium
were analyzed using immunohistochemistry and different
staining techniques such as Spicer–Meyer, Alizarin, and
extracellular DNA staining methods [32, 33]. The obtained results were visualized using various microscopic
techniques such as dark and bright field, fluorescent, and
differential interference contrast microscopy. In addition,
the antibiotic sensitivity of the different forms (spirochete
and biofilm) of the wild-type and mutant Borrelia strains
was also evaluated.
In summary, the aim of this study to provide insight of
the potential molecular pathways regulating biofilm formation in B. burgdorferi using different mutant cell lines
with the final goal to better understand how B. burgdorferi
forms biofilms. Data from this study might provide molecular targets in the future to the elimination of Borrelia
biofilms for therapeutic use.

Effect of different pathways on Borrelia biofilm

Materials and methods
Borrelia strains and culture conditions
Low passages (not more than three passages) of the wildtype 297 and mutant strains (RpoN, RpoS, and LuxS)
of B. burgdorferi were generously provided by Michael
V. Norgard’s research group (Department of Microbiology, University of Texas South-western Medical Center,
Dallas, Texas). All strains were cultured in BSK-H (Barbour–Stoner–Kelly H) media with 6% rabbit serum (PeelFreeze) by incubating at 33 °C and 5% CO2. For all the
stock mutant strains, appropriate amounts of antibiotics
were added to culture media, maintaining the mutation as
described previously [41, 53]. To visualize biofilm formation, 1 × 106 cells/ml of wild-type and mutant strains of
B. burgdorferi were inoculated in four-well chamber glass
slides (Thermo Fisher Scientific, Lab-Tek II chamber glass
slides) and were incubated for 7 days at 33 °C and 5%
CO2. For biofilm quantitative assays, 1 × 106 cells/ml of
wild-type and mutant strains of B. burgdorferi were inoculated in a 48-well tissue culture plates without any antibiotics and incubated for different times as described below.
Spicer & Meyer mucopolysaccharide staining
The wild-type 297, RpoN, RpoS, and LuxS mutant strains
of B. burgdorferi were incubated as described above for
7 days. These aggregates were fixed on the slides with
chilled (−20 °C) 1:1 mixture of acetone–methanol for
5 min. Aldehyde fuchsine solution (Sigma-Aldrich, 0.5%
fuchsine dye, 6% acetaldehyde in 70% ethanol with 1%
concentrated hydrochloric acid) was used to stain the
biofilm for 20 min at room temperature (RT). The slides
were dipped in 70% ethanol for 1 min and then rinsed with
double distilled water for 1 min followed by staining with
1% Alcian blue 8GX (Sigma-Aldrich, dissolved in 3%
acetic acid, pH 2.5) for 30 min at RT. Then, after rinsing
the slides with double distilled water for 3 min, they were
dehydrated with graded ethanol (50%, 70%, and 95%,
3 min each), then dipped in chilled xylene for 2 min, and
were mounted with Permount media (Fisher Scientific).
Immunohistochemistry
Anti-alginate rabbit polyclonal IgG antibody (generous
gift from G. Pier, Harvard University) was used to detect
alginate expression by the aggregates of the wild-type 297,
RpoN, RpoS, and LuxS mutant strains of B. burgdorferi.
Biofilms were established and cultured as described above
on four-well chamber slides for 7 days. The resulting
structures were washed twice with PBS pH 7.4 and fixed
in −20 °C using 100% methanol for 10 min and washed
then twice with PBS pH 7.4 at RT. The specimens were
then pre-incubated with 10% normal goat serum (Thermo
Scientific) in PBS/0.5% bovine serum albumin (BSA, Sig-
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ma) for 30 min at RT to block nonspecific binding of the
secondary antibody. Then, the primary alginate antibody
(1:100 dilution in dilution buffer: PBS pH 7.40 + 0.5%
BSA) was applied and the slides were incubated overnight at 4 °C in a humidified chamber. After washing,
specimens were incubated for ½ h with a 1:200 dilution
of DyLight 594 conjugated goat anti-rabbit IgG (Thermo
Scientific) at RT. The slides were then washed thrice with
PBS/0.5% BSA for 10 min, then incubated at 37 °C for 1 h
with FITC-labeled Borrelia-specific polyclonal antibody
(#73005 Thermo Scientific, diluted 1:50 in 1% BSA/1×
PBS, pH 7.4). It was followed by further washing of slides
thrice with PBS/0.5% BSA for 10 min at RT and counterstaining with 4',6-diamidino-2-phenylindole (DAPI) for
10 min. Then, after washing it again with PBS pH 7.4 for
5 min at RT, the specimens were mounted using PermaFluor aqueous mounting medium and the obtained images
were analyzed by fluorescent microscopy.
Alizarin calcium staining
In order to evaluate the presence of calcium on the surface
of B. burgdorferi biofilms, 1 × 106 cells/ml of wild-type
and mutant strains of Borrelia were grown in four-well
chamber slides for 7 days, washed twice with PBS pH 7.4,
fixed with ice-cold acetone for 5 min, and hydrated with
graded alcohol and then stained with 2% Alizarin Red-S
pH 4.2 (Sigma-Aldrich #A5533) (calcium-specific stain)
for 4 min at RT and then were washed twice with double
distilled water, dehydrated, and mounted with Permount
media.
Extracellular DNA staining
To evaluate the extracellular DNA on the aggregates and
individual spirochetes, 1 × 106 cells/ml of the wild-type
297 and RpoN, RpoS, and LuxS mutant strains of B. burgdorferi were grown on four-well chamber slides for 7 days.
The resulting aggregates washed twice with 1× TE buffer
pH 8.0. The extracellular DNA was visualized by staining the biofilms with 1 μM DDAO [7-hydroxy-9H-(1,3dichloro-9,9 dimethylacridin-2-one)] for 30 min at 37 °C
in dark. The slides were then washed twice in 1× TE buffer
pH 8.0 and mounted with PermaFluor aqueous mounting
medium (Thermo Scientific).
Quantification of B. burgdorferi biofilms by crystal
violet and total carbohydrate methods
The overall mass of the wild-type and mutant Borrelia biofilms was quantified by crystal violet methods described
earlier [3, 34]. Briefly, seven-day-old aggregates (starting
culture of 5 × 106 spirochetal cells) were scraped from the
slides and collected by centrifugation method (5000g for
10 min at RT) and were stained with 0.01% (w/v) crysEuropean Journal of Microbiology and Immunology
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tal violet 10 min at room temperature. The crystal violet
stain was discarded by centrifugation method (5000g for
10 min at room temperature) and washed twice with sterile
double-distilled water to remove all traces of crystal violet
dye; then, 100 microliter 95% ethanol was added and incubated for 15 min at RT, and absorbance was measured at
595 nm using a BioTek spectrophotometer.
Total carbohydrate assay was also used to detect all
forms of carbohydrates, including simple and complex saccharides, glycans, glycoproteins, and glycolipids as recent
studies utilized successfully this method to measure and
quantify the formation of extrapolysaccaharide layer of the
biofilms as described earlier [32]. Briefly, seven-day-old
aggregates (starting culture of 5 × 106 spirochetal cells)
were scraped from the slides and collected by centrifugation method (5000g for 10 min at RT). After removing the
supernatant, pellets were resuspended in double-distilled
H20 (0.2 mL) followed by 5% aqueous phenol (wt/vol,
Sigma) and 0.5 ml of concentrated sulfuric acid (H2SO4)
and incubated for 30 min at RT. The developed yellow/orange color was measured at 485 nm using a BioTek spectrophotometer.
Baclight (Live/Dead) staining of Borrelia aggregates
To visualize live and dead cells for Borrelia aggregates,
Baclight Live/Dead viability staining kit (Invitrogen) was
used following manufacturer instructions. Briefly, a 1:1
mixture of SYTO9 and propidium iodide stain prepared
above was added directly to the cultures in the four-chamber glass slides. The plate was then covered with aluminum foil and incubated for 15 min at RT. The four chambers were separated from the slide, washed, and mounted,
and pictures were taken under the Leica microscope using
fluorescent microscopy.

replicates were prepared for each treatment condition, and
three independent experiments were performed. After the
treatment period, aggregates are quantified by crystal violet and sulfuric acid-phenol digestion total carbohydrate
assay.
Statistical analysis
Each assay was carried out in three independent experiments with six replicates/condition, and numerical average
was obtained for data presentation. Unpaired, two-tailed
TTEST of unequal variance sample was performed to determine p values and statistical difference of two distinct
sample sets. Differences were considered statistically significant when p values are <0.05.

Results
The growth pattern of B. burgdorferi wild-type
and mutant strains
Evaluation of spirochete growth pattern in the wild-type
and mutant B. burgdorferi 297 strains from day 0 to day 8
were performed by using 8 × 105/ml spirochetes and cultured as described in Materials and methods. The results
of the obtained growth curves showed the standard threephase growth: lag, exponential/log, and stationary growth
(Fig. 1). Doubling time of all mutants (RpoNΔ, RpoSΔ,
and LuxS∆) was similar to that of the 297 wild-type strain.

Spirochete growth inhibition assay
For all antimicrobial sensitivity assays, early log-phase
spirochete cultures (5 × 105 cells/ml) from the wild-type
and mutant strains were prepared in fresh medium without antibiotics and treated with different concentration of
doxycyline for 48 h of treatment. Spirochete count was estimated by direct counting of live/motile spirochetes dark
field microscopy. Six replicates were prepared for each
treatment condition and three independent experiments
were performed. Percentage of control was calculated by
normalization of spirochete counts to the control treatment
(no doxycycline) of the same strain.
Biofilm microbial sensitivity assay
Seven-day-old aggregates (starting culture of 5 × 106 spirochetal cells) in 1 mL suspension were treated with different concentration of doxycycline for 48 h days. Six
European Journal of Microbiology and Immunology

Fig. 1. The dynamic of the spirochetal growth of the wild-type
and mutant B. burgdorferi 297 strains. Spirochetes at starting
concentration at 8 × 105 cells/ml were cultured for 8 days as
described in Materials and methods, and their cellular growth
was evaluated by direct counting method of motile spirochetes
using dark field microscopy. Each time point was carried out in
three independent experiments with six replicates/condition

Effect of different pathways on Borrelia biofilm

However, RpoN and RpoS mutants exhibited a delay in
the transition from exponential/log phase to stationary
growth, resulting in a higher maximum spirochete density: 1 × 108 compared to 5 × 107 in wild type. Figure 1
demonstrates that the RpoN mutant entered the stationary
growth only on day 6, followed by RpoS mutant and wildtype 297 strains on day 4. On the other hand, LuxS mutant
displayed a longer log phase compared to other strains but
still had maximal spirochete density that was similar to
wild-type strain on day 8.
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spectively). When crystal violet method used to measure
the total mass of the different aggregates, there was a significant reduction in the aggregate formation by RpoNΔ
strain when compared to the wild-type 297 strain (22%
reduction, p < 0.05). Comparing RpoSΔ and LuxS∆ aggregates to the wild-type strain, there was a 16% reduction and 39% in the total aggregate masses, respectively
(p < 0.05). Interestingly, when total carbohydrate method
was used to quantify the total carbohydrate component of
the different aggregates, no significant difference could be
found between the different mutant and wild-type strains
(Fig. 3B).

Analysis of aggregates formed by different mutant
strains and wild type of B. burgdorferi strains
In the next experiments, the aggregates produced by the
wild-type and mutant strains of B. burgdorferi were analyzed by dark field microscopy. Microscopic pictures of
Borrelia strains on glass slides of the four-well chambers
after 7 days of incubation of 5 × 106 cells/ml seeding concentration were compared for the presence of potential aggregate presence. The result showed that aggregates were
formed in the 297 wild type as well as all three mutant cultures (Fig. 2). Morphologically, mutants seemed to exhibit
a higher tendency to form loose, dispersed, and smaller
aggregates than wild-type strain, especially LuxS∆ mutant
strains, which showed a reticular mesh structure (Fig 2).
The quantification of aggregates formed by different
mutant and wild-type strains was performed using crystal
violet and total carbohydrate methods (Fig. 3A and B, re-

Presence of specific biofilm markers on the surface of
the aggregates of different B. burgdorferi strains
Wild-type 297 and various mutant strains of B. burgdorferi
were tested for the presence of the previously described
Borrelia biofilm specific markers such as sulfated/nonsulfated polysaccharides, alginate, calcium, and extracellular DNA.
1. Sulfated/non-sulfated mucins
Spicer & Meyer staining method was used to examine the
presence of sulfated and non-sulfated/carboxylated mucins. Fuchsine stains the weakly acidic sulfomucins; purple coloration signifies strongly acidic sulfomucins, and
alcian blue stain is specific for non-sulfated/carboxylated
mucins. The aggregates formed by the wild-type and the

Fig. 2. Representative images of aggregates formed by 297-WT (A), RpoN∆ (B), RpoS∆ (C), and LuxS∆
(D) strains of B. burgdorferi as depicted by dark field microscopy. 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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Fig. 3. Quantitative analysis of the total mass content of the aggregates formed by 297-WT, RpoNΔ, RpoSΔ, and LuxSΔ using crystal violet method (panel A) or total carbohydrate methods (panel B). Each assay was carried out in three independent experiments
with six replicates/condition. *p values < 0.05 indicates statistical significance as related to the 297-WT control strain

different mutant strains (RpoN∆, RpoS∆, and LuxS∆) of
B. burgdorferi were stained as described in Materials and

methods and imaged with dark field microscopy (Fig. 4).
The colors developed in the center of the all three mutant

Fig. 4. Spicer & Meyer mucopolysaccharide staining by dark field microscopy of the wild-type 297 (A) and the mutant RpoN (B),
RpoS (C), and LuxS (D) B. burgdorferi strains. Fuchsia color indicates weakly acidic sulfomucins; purple color indicates strongly
acidic sulfomucins/sulfated proteoglycans; blue color indicates non-sulfated/carboxylated mucins. 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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strains showed some blue staining pattern (non-sulfated
mucin), but contrary to wild-type 297, it was very dispersed. The periphery of the biofilms of all mutant strains
studied stained mainly fuchsia purple color indicating sulfated mucins similar to the mucins found in the 297 wildtype strain.
2. Alginate
Spicer & Meyer mucopolysaccharide staining results
showed the presence of some non-sulfated mucins on all of
the mutant strain biofilms. The non-sulfated mucins could
indicate the presence of alginate as described previously

7

for both B. burgdorferi B31 and 297 strains [32, 33]. The
presence of alginate on the surface of the wild-type and
the mutant strains of Borrelia species was confirmed by
performing a previously published and validated method
of double immunohistochemical staining with anti-alginate and anti-Borrelia antibodies (Fig. 5A–K). All mutant
strains, RpoN, RpoS, and LuxS, were strongly stained
with anti-Borrelia (Fig. 5D, G, and J) and anti-alginate antibodies (Fig. 5E, H, and K) similar to the wild-type 297
strains (Borrelia – green staining, Fig. 5A; alginate – red
staining, Fig. 5B, respectively). Similarly to the wild-type
strain, only the center of the aggregates stained with al-

Fig. 5. Immunohistochemical staining of wild-type 297, RpoN, RpoS, and LuxS mutant strains of B. burgdorferi with Borreliaspecific (green staining, panels A, D, G, and J) and alginate antibodies (red staining, panels B, E, H, and K) as described in Materials and methods. DAPI counterstain (blue staining, panels C, F, I, and L) indicates nuclear staining. Yellow arrowheads indicate
spirochetes not stained with alginate. 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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Fig. 6. Aggregates of 297 (A), RpoN (B), RpoS (C), and LuxS (D) strains of B. burgdorferi stained with calcium specific stain,
Alizarine, as described in Materials and methods. Red color indicates calcium analyzed by dark field microscopy. Black arrowheads indicate spirochetes not stained with Alizarine. 400× magnification, bar: 200 μm

ginate antibody but not the surrounding spirochetes, indicating the specificity of the alginate staining technique as
well as that fact that individual spirochetes do not express
alginate (yellow arrow) as described in our previous reports [32, 34].
3. Presence of calcium
It was previously reported that alginate is associated with
calcium to form insoluble calcium alginate and calcium
was found on the surface of both B. burgdorferi B31 and
297 strains. The potential presence of calcium on the surface of different aggregates formed by the wild-type and
the different mutant strains was tested by using Alizarin
calcium staining method. The aggregates of all mutant
strains RpoN, RpoS, and LuxS were stained red color with
Alizarin Red-S stain similar to the wild-type 297 strain,
indicating the presence of calcium in all strains studied
(Fig. 6, panels A, B, C, and D). As previously reported for
the wild-type 297 strain [32], the individual spirochetes
were not stained with the calcium stain (indicated in Fig. 6
with black arrowheads), suggesting that calcium is specific
to the surface of the aggregates formed by the wild-type
and all mutants strains studied.
4. Extracellular DNA
Finally, the aggregates formed by the wild-type and mutant strains were examined for the presence of extracellular DNA (eDNA) as it was described for B. burgdorferi
biofilm before [32]. For the detection of eDNA, a red fluorescent dye (7-hydroxy-9H-(1,3-dichloro-9,9-dimethylEuropean Journal of Microbiology and Immunology

acridin-2-one (DDAO)) was used as reported previously
[32]. The aggregate surfaces of the wild-type 297 and the
RpoN, RpoS, and LuxS mutant strains were found to have
significant amount of eDNA (Fig. 7, panels B, D, F, and
H, respectively) whereas the surrounding individual spirochetes did not show staining for eDNA (indicated by yellow arrowheads). The DAPI nuclear counter stain images
(Fig. 7, panels A, C, E, and G) depicted the size and morphology of the wild-type and mutant aggregates.
Effect of doxycyline on the wild-type and different
mutant strains of B. burgdorferi
The goal of the next experiments is to compare the response
of the early log phase spirochetal rich and stationary phase
aggregate rich cultures of the wild-type and mutant strains
to antibiotic stress. The effects of doxycycline on the spirochetal form of B. burgdorferi in the wild-type 297 and
mutant strains (RpoN∆, RpoS∆, and Lux∆) were studied
using first early log phase spirochetes and direct counting
of the live/motile cells with dark field microscope. Wildtype and mutant spirochetes were treated with various
concentrations of doxycycline (ranging from published
MIC and MBC concentrations) for 48 h, and the number
of motile spirochetes in each treatment was counted. Spirochete numbers were normalized to their no antibiotic
control of the same strains (0 μg/ml doxycycline) as depicted in Fig. 8. For all B. burgdorferi strains, doxycycline
treatments that significantly reduced the live spirochete

Effect of different pathways on Borrelia biofilm

counts in every concentration were studied. More specifically, as doxycycline concentration increased from zero to
1 μg/ml, spirochetes decreased in number from 100% to
15–20% in every strain. Significant differences between
the wild-type 297 and all mutant strains (RpoN∆, RpoS∆,
and Lux∆) were found (marked with #) when 0.1 μg/ml of
concentration was used for treatment, while 1 μg/ml doxycyline concentration showed more significant results only
in RpoN∆ and RpoS∆ strains but not in the LuxS∆ strain.

9

Interestingly, however, 10 μg/ml doxycyline treatment did
not produce significantly different results in any of the mutant strains compared to wild-type Borrelia strain.
In the next step of experiments of the crystal violet,
total carbohydrate assay and Baclight Live/Dead staining methods were used to study the effect of doxycycline
on the viability of the stationary phase aggregates formed
by the wild-type and mutant B. burgdorferi strains. Crystal violet measured the changes in total mass while total

Fig. 7. Aggregates of the wild-type 297, RpoN, RpoS, and LuxS strains of B. burgdorferi stained eDNA with DDAO fluorescent dye
specific for extracellular DNA as described in Materials and methods (panels B, D, F, and H). DAPI nuclear counterstain was used
to demonstrate the structure of the different aggregates (panels A, C, E, and G). Red fluorescent color indicates eDNA as depicted
by fluorescent microscopy. Yellow arrowheads indicate spirochetes not stained with DDAO. 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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Fig. 8. Effect of different concentrations of doxycycline on the spirochetal form of wild-type 297 and RpoN∆, RpoS∆, and LuxS∆
strains of B. burgdorferi. The data analyzed by direct counting of the motile spirochetes using dark field microscopy. Each assay
was carried out in three independent experiments with six sample replicates/condition, and the data were normalized to the no antibiotic treatment control for each strain. * indicates statistical significance as related to the corresponding no antibiotic control, and
# indicates statistical significance as related to the 297-WT corresponding control sample

Fig. 9. Effect of different concentrations of doxycycline 48 h treatment on the biofilm form of wild-type 297 and RpoN∆, RpoS∆,
and LuxS∆ mutant strains of B. burgdorferi after 48 h treatment analyzed by total carbohydrate methods as described in Materials
and methods. Each assay was carried out in three independent experiments with six sample replicates/condition, and the data were
normalized to the no antibiotic treatment control for each strain. * indicates statistical significance as related to the corresponding
no antibiotic control, and # indicates statistical significance as related to the 297-WT corresponding control sample

carbohydrate assay was used to detect changes in the extracellular polysaccharide layer of the aggregates before
and after antibiotic treatment. Baclight Live/Dead staining
method directly visualized the effect of the doxycycline by
depicting the live (green) and dead (red) population in the
aggregates of the different Borrelia strains. Seven-day-old
aggregate rich cultures (starting culture of 5 × 106 spirochetal cells) in 1 mL suspension were treated with different
concentration of doxycycline (ranging from 0 to 10 μg/ml
concentration) for 48 h. Data from all antibiotic-treated
samples were normalized to their no antibiotic control of
the same strains (0 μg/ml doxycycline). When crystal violet method was used to evaluate doxycyline sensitivity of
the wild-type and all three mutant strains, there were no
significant differences found for any of the experimental
European Journal of Microbiology and Immunology

condition for any strains studied (data not shown). However, when the total carbohydrate assay was used to assess
doxycyline sensitivity, there were significant differences
found in all three mutant strains compared to the wild-type
control as depicted in Fig. 9. While doxycyline treatment
of 297 wild-type strain did not reduce the extracellular
polysaccharide layer significantly at any of the antibiotic
concentrations, all there mutant strains (RpoN∆, RpoS∆,
and Lux∆) showed reduction of their extracellular polysaccharide layer at 10 μg/ml (20–60%). The most dramatic
effect, however, was found in the doxycyline sensitivity of
the LuxS∆ strain, indicating that all three concentrations of
doxycyline (0.1, 1, and 10 μg/ml) significantly reduced the
extracellular polysaccharide layer (Fig. 9). The reduction
was significant when it was compared to both the LuxS∆
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control and 297 wild-type control (p value < 0.01). Furthermore, while the effect of 10 μg/ml of doxycyline was
significant for the extracellular polysaccharide layer of the
RpoN∆ and RpoS∆ strains when it compared to their no
treatment controls (p value < 0.05), it was not significantly
different than the wild-type control data with the same
doxycyline treatment.
To further confirm the quantitative data of the doxycyline effect on the different strains, Baclight Live/Dead
analyses were performed on the 10 μg/ml doxycylinetreated cultures after 48 h. Figure 10 shows representative microscopic images obtained from the untreated and
doxycycline-treated wild-type 297 and mutant B. burg-

11

dorferi strains (RpoN∆, RpoS∆, and Lux∆) strains depicting membrane-intact (live) cells in green and membranepermeable (dead) cells in red. In all of the no treatment
controls (Fig. 10, panels A, C, E, and G), majority of the
cells show green staining indicating live cells with a small
portion of the cells stained red indicating dead cells. In
the doxycyline-treated cultures, the majority of the cells
stained green for the wild-type 297 and the RpoN∆ mutant
cells show no significant difference from their no treatment control cultures. For RpoS∆ strain, there were a portion of the aggregates (<10%) which showed higher numbers of dead cells, but overall, the difference from the no
treatment control was not significant. On the other hand,

Fig. 10. Representative Baclight Live/Dead images of the effect of doxycycline on the aggregate forms of wild-type 297 (panels A
and B) and RpoN∆ (panels C and D), RpoS∆ (panels E and F), and LuxS∆ (panels G and H) strains of Borrelia burgdorferi after
48 h treatment with 0 (panels A, C, E, and G) or 10 μg/ml (panels B, D, F, and H) of doxycyline as analyzed using fluorescent microscopy. Green color = live cells, red color = dead cells, 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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majority (>95%) of the aggregates of the LuxS strains
showed mainly red/dead cells after 48 h of antibiotic treatment, suggesting a greater sensitivity to doxycyline than
the wild-type 297 or the Rpo gene mutant strains.

Discussion
In this study, the possible biofilm formation of several
mutant strains of B. burgdorferi was investigated to better
understand the roles of different genes–intracellular pathways in the development and characteristic of Borrelia
biofilm.
Building a biofilm community requires intra- and extracellular communication processes and is considered a
survival response in bacteria [36–38]. Rpo transcriptional
factor genes are known to control bacterial changes in response to environment stimuli [40]; LuxS quorum-sensing
roles in biofilm formation and antibiotic response have
been established in some research with other organisms
[47–50]. This study attempted to explore the possible roles
of Rpo genetic regulation and LuxS quorum communication pathways in Borrelia biofilm formation and its antibiotic sensitivity.
Growth patterns of planktonic spirochetes were compared between the wild-type and the different mutant
strains. The results showed that RpoN, RpoS, and LuxS
mutant strains had some deviations from wild-type strains,
including that mutants lacking Rpo genes had longer time
to response to the inadequate nutrient environment, resulting in a longer exponential growth period and, ultimately,
the higher maximum spirochete density. LuxS mutant
reached the stationary phase later, suggesting that LuxS
could also have a potential role in the growth of B. burgdorferi.
Furthermore, in spite of lacking important genes responsible for regulating bacterial environmental responses
and quorum-sensing communication, all three mutants
readily formed biofilm-like aggregates in the stationary phase of growth. Morphologically, all mutants but
especially the LuxS mutant seemed to exhibit a higher
tendency to form smaller and looser aggregates than the
wild-type strain. This result is in good agreement with a
previous study in which mutation in rpoS did not eliminate
the biofilm formation in Escherichia coli during exponential phase of growth [54, 55].
The size of the aggregates was also quantified in this
study using crystal violet staining as well as total carbohydrate quantitation methods. The obtained data indicated
that mutant aggregates were significantly smaller than the
wild-type ones; however, those smaller aggregates had
similar amounts of total carbohydrate, suggesting that the
mutants might produce higher amounts of protective mucopolysaccharide layers. This finding is in good agreement
with a study, in which Pseudomonas aeruginosa mutant
had increased matrix production [56].
Further investigation of specific biofilm markers in the
mutant strains showed that all three mutant strains produce
European Journal of Microbiology and Immunology

significant amounts of biofilm specific markers such as
sulfated/non-sulfated polysaccharides, alginate, calcium,
and eDNA, similar to what was found and reported previously to the wild-type B. burgdorferi strains [52, 53].
These results strongly suggest that the aggregates formed
by the mutant strains studied are indeed biofilms.
It might be surprising at first that Borrelia strains lacking RpoN, RpoS, and LuxS genes still can form biofilms which could have most of the main phenotypes of
the wild-type biofilm. However, in earlier studies, it was
reported that mutant strains of RpoN in E. coli K12 and
Enterococcus faecalis also formed biofilms [57, 58]. RpoS
mutant strain was also observed to form biofilm in E. coli
ZK126 stains as well as in P. aeroginosa [59, 60]. For LuxS
mutant strain in Streptococccus sp., a report suggested that
the mutant LuxS mutant could form biofilm; however, it
depends on the in vitro culture condition [61, 62].
One of main differences found for the Borrelia mutant
biofilms was the reduced size compared to wild-type 297.
The RpoN mutant strain of B. burgdorferi formed a biofilm which was 22% less in size than the wild-type 297.
Previously, it was reported that the deletion of RpoN gene
in E. coli K12 strains increased the biofilm formation by
40–60%, and also in E. faecalis, the RpoN mutant strain
was observed to form robust biofilms [57, 58]. In this study,
we showed that RpoS mutant strain of B. burgdorferi had
16% reduction in the biofilm formation compared to wildtype similar to the deletion of RpoS gene in E. coli ZK126
which reduced the biofilm size by 50% [59]. LuxS mutant strain of B. burgdorferi formed biofilm which showed
39% significant reduction in size which agrees with the
report on Streptococccus sp. LuxS mutants [61].
Also, there were slight morphological differences observed in the biofilms formed by the RpoN, RpoS, and
LuxS Borrelia mutant strains compared to wild-type
strain. The biofilm formed by the wild-type 297 strain
shows a compact biofilm mass which resembles the biofilm of B31 strain of B. burgdorferi as described in our
recently published paper [32, 33]. The biofilm formed by
RpoN mutant was relatively less compact compared to
wild-type biofilms while RpoS mutant strain formed many
loose and dispersed small aggregates unlike the wild-type
297. Interestingly, the biofilm formed by RpoS mutant of
P. aeroginosa was denser and thicker than the wild type
[60]. The biofilm formed by LuxS mutant strain of Borrelia represents a very loose reticular mesh. Undifferentiated and loosely-connected biofilms were also found
to form in LuxS mutant strain of Shewanella oneidensis
covering the entire glass surface uniformly unlike the
wild type which forms compact biofilms with significant
amounts of spaces in between [63].
Biofilms were demonstrated to be responsible for the
antibiotic resistance in many species [36–39]. Therefore,
besides examining the growth dynamics and biofilm development of the different mutant strains of B. burgdorferi, this research attempted to compare the responses of
wild-type and mutant strains to antibiotic stress. Early
log phase spirochetes and stationary phase aggregate
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rich cultures were exposed to varying concentrations of
doxycycline and compared among all strains studies. In
a good agreement with several recent studies using wildtype B. burgdorferi 31 strain, only the early log phase
spirochetes of the wild-type 297 strains were sensitive to
doxycyline treatment but not the aggregate rich stationary
phase cells [3–6]. When the doxycyline sensitivity of the
early log phase spirochetes of the wild-type strain and all
of the three mutant strains was compared, the obtained results indicated significantly higher sensitivity of all three
mutant strains to low MIC dose of doxycyline (0.1 μg/ml)
than the wild-type strain. Interestingly, however, there was
no difference in the doxycyline sensitivity of the early log
phase spirochetes among the strains at higher MBC level
concentration.
Similarly, doxycyline sensitivity of the stationary aggregate rich cultures of wild-type and Rpo mutants was not
significantly different at lower doses. In contrary, however,
antibiotic sensitivity of the LuxS Borrelia mutant dramatically greater than the wild-type mutant at all concentrations was studied. These later results were also confirmed
by microscopical analyses of the live and dead cells of the
mutant strains as demonstrated by Baclight Live/Dead
staining. In summary, the antibiotic sensitivity studies of
the mutant strains confirmed that all three genes have some
effect on antibiotic sensitivity in some extent but LuxS
mutant has the most significant effect.
Involvement of LuxS signaling pathway in antibiotic
sensitivity was proven for S. anginosus species, in which
the mutant demonstrated increased susceptibility to erythromycin and ampicillin [64]. Furthermore, P. aeruginosa
mutants defective in interspecies quorum sensing produced weaker biofilms that were more sensitive to detergents, while Streptococcus mutans mutants defective in
interspecies cell signaling generated stronger biofilms that
were more resistant to detergents [61, 65].
In our recent studies, we also investigate the potential
biofilm formation of several other B. burgdorferi mutants
such as the Hk1/Rrp1 and recA mutants that regulate the
cyclic di-GMP and the recombination events, respectively
[38, 66, 67]. Those two molecular pathways were already
implicated to be important in biofilm formation for other
bacterial species [38]; however, our preliminary findings
show no differences from the wild-type strains in regards
of different aspects of biofilm development and characteristic (data not shown).
In summary, our findings strongly suggest that several
alternative pathways could regulate B. burgdorferi biofilm
formation, a result that indicates that it is a very important
survival mechanism for this bacterium. Findings for the
potential importance of the LuxS quorum-sensing pathways for Borrelia biofilm development and antibiotic sensitivity merit further investigation of this pathway.
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